Plasma SPARC Elevation in Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage
Neurotherapeutics · 2023-04 · 20 (3) · 779-788
DOI: 10.1007/s13311-023-01351-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurotherapeutics, 2023-04. Verfasst von Hideki Nakajima und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Mie University Graduate School of Medicine, Tsu, Japan. Hauptthemen laut MEDLINE: Subarachnoid Hemorrhage, Brain Ischemia. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Japan Society for the Promotion of Science, Sanikai Foundation, OKASAN-KATO FOUNDATION.
Abstract (Originalsprache)
Matricellular proteins have been implicated in pathologies after subarachnoid hemorrhage (SAH). To find a new therapeutic molecular target, the present study aimed to clarify the relationships between serially measured plasma levels of a matricellular protein, secreted protein acidic and rich in cysteine (SPARC), and delayed cerebral ischemia (DCI) in 117 consecutive aneurysmal SAH patients with admission World Federation of Neurological Surgeons (WFNS) grades I-III. DCI developed in 25 patients with higher incidences of past history of hypertension and dyslipidemia, preoperative WFNS grade III, modified Fisher grade 4, spinal drainage, and angiographic vasospasm. Plasma SPARC levels were increased after SAH, and significantly higher in patients with than without DCI at days 7-9, and in patients with VASOGRADE-Yellow compared with VASOGRADE-Green at days 1-3 and 7-9. However, there were no relationships between plasma SPARC levels and angiographic vasospasm. Receiver-operating characteristic curves differentiating DCI from no DCI determined the cut-off value of plasma SPARC ≥ 82.1 ng/ml at days 7 - 9 (sensitivity, 0.800; specificity, 0.533; and area under the curve, 0.708), which was found to be an independent determinant of DCI development in multivariate analyses. This is the first study to show that SPARC is upregulated in peripheral blood after SAH, and that SPARC may be involved in the development of DCI without angiographic vasospasm in a clinical setting.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Mie University Graduate School of Medicine, Tsu, Japan.
- Department of Neurosurgery, Mie University Graduate School of Medicine, Tsu, Japan. suzuki02@med.mie-u.ac.jp.
ORCID-Profile: Hidenori Suzuki
Förderung
- Japan Society for the Promotion of Science
- Sanikai Foundation
- OKASAN-KATO FOUNDATION
- Taiju Life Social Welfare Foundation
Zitieren
APA
Nakajima, H., Kawakita, F., Oinaka, H., Suzuki, Y., Nampei, M., Kitano, Y., Nishikawa, H., Fujimoto, M., Miura, Y., Yasuda, R., Toma, N., Suzuki, H., & pSEED group (2023). Plasma SPARC Elevation in Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage. Neurotherapeutics, 20(3), 779-788. https://doi.org/10.1007/s13311-023-01351-x
Vancouver
Nakajima H, Kawakita F, Oinaka H, Suzuki Y, Nampei M, Kitano Y, et al. Plasma SPARC Elevation in Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage. Neurotherapeutics. 2023;20(3):779-788. doi:10.1007/s13311-023-01351-x
BibTeX
@article{Nakajima2023,
author = {Nakajima, Hideki and Kawakita, Fumihiro and Oinaka, Hiroki and Suzuki, Yume and Nampei, Mai and Kitano, Yotaro and Nishikawa, Hirofumi and Fujimoto, Masashi and Miura, Yoichi and Yasuda, Ryuta and Toma, Naoki and Suzuki, Hidenori and pSEED group, pSEED group},
title = {Plasma SPARC Elevation in Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage},
journal = {Neurotherapeutics},
year = {2023},
volume = {20},
number = {3},
pages = {779--788},
doi = {10.1007/s13311-023-01351-x}
}
EUVIMED